Assessment of tissue viability after frostbite injury by technetium-99m- sestamibi scintigraphy in an experimental rabbit model

European Journal of Nuclear Medicine

Volumn 27, Issue 1, 2000, Pages 41-45

  Sarikaya, Ismet ^a   Aygit, A Cemal ^b   Candan, Latife ^b   Sarikaya, Ali ^b   Türkyilmaz, Murat ^b   Berkarda, Şakir ^b  

^a KOCAELI UNIVERSITY   (Turkey)

^b TRAKYA UNIVERSITY   (Turkey)

Author keywords

Frostbite; Scintigraphy; Technetium 99m sestamibi

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLD INJURY; FEMALE; HINDLIMB; HISTOPATHOLOGY; LEG MUSCLE; MALE; MUSCLE ISCHEMIA; MUSCLE NECROSIS; NONHUMAN; RABBIT; REPERFUSION; SCINTIGRAPHY; TISSUE INJURY; TISSUE PERFUSION;

EID: 0033954532     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00006660     Document Type: Article

References (44)

1. 1. Knize DM, Weatherley-White RC, Paton BC, Owens JC. Prognostic factors in the management of frostbite. J Trauma 1969; 9: 749-759.
2. 2. Salimi Z, Vas Wenzel, Tang-Bartom P, Eachempati RG, Morris L, Carron M. Assessment of tissue viability in frostbite by Tc99m pertchnetate scintigraphy. AJR Am J Roentgenol 1984; 142: 415-419.
3. 3. Murray JF. Cold, chemical, and irradiation injuries. In: McCarthy, ed. Plastic surgery. Philadelphia: Saunders; 1990; 5431-5451.
4. 4. Kiat H, Maddahi J, Roy LT, Van Train K, Friedman J, Resser K, Berman DS. Comparison of technetium 99m isonitrile and thallium 201 for evaluation of coronary artery disease by planar and tomographic methods. Am Heart J 1989; 117: 1-11.
5. 5. Sayman HB, Urgancioglu I. Muscle perfusion with technetium-MIBI in lower extremity peripheral arterial disease. J Nucl Med 1991; 32: 1700-1703.
6. 6. Miles KA, Barber RW, Wraight EP, Cooper M, Appleton DS. Leg muscle scintigraphy with Tc99m-MIBI in the assessment of peripheral vascular [arterial]disease. Nucl Med Commun 1992; 13: 563-603.
7. 7. Bajnok L, Kozlovsky B, Varga J, Antalffy J, Olvaszto S, Fülöp T Jr. Technetium-99m sestamibi scintigraphy for the assessment of lower extremity ischaemia in peripheral arterial disease. Eur J Nucl Med 1994; 21: 1326-1332.
8. 8. Gage AM, Gage AA. Frostbite. Trauma Emerg Med 1981; 7: 25-30.
9. 9. Daum PS, Bowers Jr W, Tejada J, Hamlet MP. Vascular casts demonstrate microcirculatory insufficiency in acute frostbite. Cryobiology 1987; 24: 65-73.
10. 10. Bourne MH, Piepkorn MW, Clayton F, Leonard LG. Analysis of microvascular changes in frostbite. J Surg Res 1986; 40: 26-35.
11. 11. Weatherly-White RCA, Sjostrom B, Paton B. Experimental studies in cold injury - the pathogenesis of frostbite. J Surg Res 1964; 4: 17-22.
12. 12. Kulka JP. Cold injuries of the skin: the pathogenic role of microcirculatory impairment. Arch Environ Health 1965; 11: 484-497.
13. 13. Heggers JP, Robson MC, Manavalen K, Weingarten MD, Carethers JM, Boertman JA, Smith DJ Jr, Sachs RJ. Experimental and clinical observations on frostbite. Ann Emerg Med 1987; 16: 1052-1062.
14. 14. Zook N, Hussmann J, Brown R, Russell R, Kucan J, Roth A, Suchy H. Microcirculatory studies of frostbite injury. Ann Plast Surg 1998; 40: 246-253.
15. 15. McCauley RL, Hing DN, Robson MC, Heggers JP. Frostbite injuries: a rational approach based on the pathophysiology. J Trauma 1983; 23: 143-147.
16. 16. Salimi Z, Wolverson MK, Herbold DR, Vas W, Salimi A. Treatment of frostbite with i.v. streptokinase: an experimental study in rabbits. AJR Am J Roentgenol 1987; 149: 773-776.
17. 17. Skolnick AA. Early data suggest clot-dissolving drug may help save frostbitten limbs from amputation (news). JAMA 1992; 267: 2008-2010.
18. 18. Manson PN, Jesudass R, Marzella L, Bulkley GB, Im MJ, Narayan KK. Evidence for an early free radical-mediated reperfusion injury in frostbite. Free Rad Biol Med 1991; 10: 7-11.
19. 19. Mileski WJ, Raymond JF, Winn RK, Harlan JM, Rice CL. Inhibition of leukocyte adherence and aggregation for treatment of severe cold injury in rabbits. J Appl Physiol 1993; 74: 1432-1436.
20. 20. Foray J. Mountain frostbite. Current trends in prognosis and treatment (from results concerning 1261 cases) Int J Sports Med 1992; 13: 193-196.
21. 21. Greenwald D, Cooper B, Gottlieb L. An algorithm for early aggressive treatment of frostbite with limb salvage directed by triple-phase scanning. Plast Reconstr Surg 1998; 102: 1069-1074.
22. 22. Mehta RC, Wilson MA. Frostbite injury: prediction of tissue viability with triple-phase bone scanning. Radiology 1989; 170: 511-514.
23. 23. Erikson V, Ponten B. The possible value of arteriography supplemented by a vasodilator agent in the early assessment of tissue viability in frostbite. Injury 1974; 6: 150-153.
24. 24. Sumner DS, Bpswick JA, Doolittle WH. Prediction of tissue loss in human frostbite with Xenon 133. Surgery 1971; 69: 899-903.
25. 25. Page RE, Robertson GA. Management of the frostbitten hand. Hand 1983; 15: 185-191.
26. 26. Tishlen JM. The soft tissue and bone changes in frostbite injuries. Radiology 1972; 102: 511-513.
27. 27. Lisbona R, Rosenthall L. Assessment of bone viability by scintiscanning in frostbite injuries. J Trauma 1976; 16: 989-992.
28. 28. Ikawa G, Dos Santos PA, Yamaguchi KT, Stroh-Recor C, Ibello R. Frostbite and bone scanning: the use of 99m-labelled phosphates in demarcating the line of viability in frostbite victims. Orthopedics 1986; 9: 1257-1261.
29. 29. Purdue GF, Lewis SA, Hunt JL. Pyrophosphate scanning in early frostbite injury. Am Surg 1983; 49: 619-620.
30. 30. Junila J, Torniainen P, Kaarela O, Kairaluoma MI, Waris T. Assessment of tissue viability in frostbite by Tc99m-HDP scintigraphy: an experimental study in New Zealand white rabbits. Nucl Med Commun 1992; 13: 542-546.
31. 31. Salimi Z, Wolverson MK, Herbold DR, Was W. Frostbite: experimental assessment of tissue damage using Tc-99m pyrophosphate. Radiology 1986; 161: 227-231.
32. 32. Barker JR, Haws M J, Brown RE, Kucan JO, Moore WD. Magnetic resonance imaging of severe frostbite injuries. Ann Plast Surg 1997; 38: 275-279.
33. 33. Pirozynski WJ, Webster DR. Muscle changes in experimental frostbite. Ann Surg 1952; 136: 993-998.
34. 34. Trusal LR, Guzman AW, Baker CJ. Characterization of freezethaw induced ultrastructural damage to endothelial cells in vitro. In Vitro 1984; 20: 353-364.
35. 35. Beanlands RSB, Dawood F, Wen WH, McLaughlin PR, Butany J, D'Amati G, Liu PP. Are the kinetics of technetium-99m-methoxyisobutyl isonitrile affected by cell metabolism and viability? Circulation 1990; 82: 1802-1814.
36. 36. Chiu ML, Kronauge JF, Piwnica-Worms D. Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis (2-methoxyisobutylisonitrile) technetium (I) in cultured mouse fibroblasts. J Nucl Med 1990; 31: 1646-1653.
37. 37. Bisi G, Podio V, Sciagra R. Detection of myocardial viability with 99mTc-labelled myocardial perfusion agents. Q J Nucl Med 1996; 40: 68-75.
38. 38. Von Dahl J, Altehoefer C, Sheehan FH, Buechin P, Schulz G, Schwarz ER, Koch KC, Uebis R, Messmer BJ, Buell U, Hanrath P. Effect of myocardial viability assessed by technetium-99m-sestamibi SPECT and fluorine-18-FDG PET on clinical outcome in coronary artery disease. J Nucl Med 1997; 38: 742-748.
39. 39. Levine MG, McGill CC, Ahlberg AW, White MP, Giri S, Shareef B, Waters D, Heller GV. Functional assessment with electrocardiographic gated single photon emission computed tomography improves the ability of technetium-99m sestamibi myocardial perfusion imaging to predict myocardial viability in patients undergoing revascularization. Am J Cardiol 1999; 83: 1-5.
40. 40. Dakik HA, Howell JF, Lawrie GM, Espada R, Weilbaecher DG, He ZX, Mahmarian JJ, Verani MS. Assessment of myocardial viability with 99mTc-sestamibi tomography before coronary bypass graft surgery: correlation with histopathology and postoperative improvement in cardiac function. Circulation 1997; 96: 2892-2898.
41. 41. Caner B, Beller GA. Are technetium-99m-labelled myocardial perfusion agents adequate for dedection of myocardial viability. Clin Cardiol 1998; 21: 235-242.
42. 42. Maes AF, Borgers M, Flameng W, Nuyts JL, Van de Werf F, Ausma JJ, Sergeant P, Mortelmans LA. Assessment of myocardial viability in chronic coronary disease using technetium-99m sestamibi SPECT. Correlation with histologic and positron emission tomographic studies and functional follow-up. J Am Coll Cardiol 1997; 29: 62-68.
43. 99mTc-sestamibi leg scintigraphy. Nucl Med Commun 1999 (in press).
44. 44. Aygit AC, Sarikaya A. Technetium-99m sestamibi scintigraphy for non-invasive assessment of muscle flap viability. Ann Plast Surg 1999; 43: 338-340.